Home » Knowledge Center » Industry News » FDA Approves Nausea Prevention Drug

Knowledge Center

FDA Approves Nausea Prevention Drug

By admin aapc
In Industry News
September 2, 2008
Comments Off on FDA Approves Nausea Prevention Drug

The FDA has approved a new oral formulation of ALOXI(R) (palonosetron hydrochloride) made by Eisai Corporation of North America and its partner Helsinn Healthcare SA for the prevention of chemotherapy-induced nausea and vomiting (CINV) (Medical News Today, Aug. 24).

Author
Recent Posts

<img alt='' src='https://secure.gravatar.com/avatar/d0cc7bbd7912de54d3f454a21203da77?s=250&d=mm&r=g' srcset='https://secure.gravatar.com/avatar/d0cc7bbd7912de54d3f454a21203da77?s=500&d=mm&r=g 2x' class='avatar avatar-250 photo' height='250' width='250' />

<img alt='' src='https://secure.gravatar.com/avatar/d0cc7bbd7912de54d3f454a21203da77?s=250&d=mm&r=g' srcset='https://secure.gravatar.com/avatar/d0cc7bbd7912de54d3f454a21203da77?s=500&d=mm&r=g 2x' class='avatar avatar-250 photo' height='250' width='250' />

Latest posts by admin aapc (see all)

Taking the Online CPC® Exam - August 11, 2020
CMS Proposes Medicare Telehealth Coverage in 2021 - August 7, 2020
2021 E/M Guideline Changes: Otolaryngology - August 3, 2020

Comments are closed.

Hot Topics